Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 287693, 9 pages
http://dx.doi.org/10.1155/2015/287693
Research Article

Propolis Is an Efficient Fungicide and Inhibitor of Biofilm Production by Vaginal Candida albicans

1Division of Medical Mycology, Teaching and Research Laboratory in Clinical Analyses, Department of Clinical Analysis of State University of Maringá, Avenida Colombo 5790, 87020-900 Maringá, PR, Brazil
2Laboratory of Research and Development of Drug Delivery Systems, Department of Pharmacy, State University of Maringá, Maringá, PR, Brazil
3Clinical Cytology Laboratory, Department of Clinical Analysis and Biomedicine, State University of Maringá, PR, Brazil

Received 6 June 2014; Accepted 14 September 2014

Academic Editor: Jung-Nien Lai

Copyright © 2015 Isis Regina Grenier Capoci et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. D. Sobel, “Vulvovaginal candidosis,” The Lancet, vol. 369, no. 9577, pp. 1961–1971, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. P. L. Fidel Jr. and J. E. Cutler, “Prospects for development of a vaccine to prevent and control vaginal candidiasis,” Current Infectious Disease Reports, vol. 13, no. 1, pp. 102–107, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. S. R. Fan and X. P. Liu, “In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis,” Mycoses, vol. 54, no. 6, pp. 501–505, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. X. P. Liu, S. R. Fan, Y. T. Peng, and H. P. Zhang, “Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012,” Journal of Medical Mycology, vol. 24, no. 2, pp. 106–111, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. D. P. Kontoyiannis, G. P. Bodey, and C. S. Mantzoros, “Fluconazole vs. amphotericin B for the management of candidaemia in adults: a meta-analysis,” Mycoses, vol. 44, no. 5-6, pp. 125–135, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. E. C. Almeida and H. Menezes, “Anti-inflammatory activity of propolis extracts: a review,” Journal of Venomous Animals and Toxins, vol. 8, no. 2, pp. 191–212, 2002. View at Google Scholar
  7. Y. K. Park, S. M. Alencar, and C. L. Aguiar, “Botanical origin and chemical composition of Brazilian propolis,” Journal of Agricultural and Food Chemistry, vol. 50, no. 9, pp. 2502–2506, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. G. A. Burdock, “Review of the biological properties and toxicity of bee propolis (propolis),” Food and Chemical Toxicology, vol. 36, no. 4, pp. 347–363, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Imhof, M. Lipovac, C. Kurz, J. Barta, H. C. Verhoeven, and J. C. Huber, “Propolis solution for the treatment of chronic vaginitis,” International Journal of Gynecology and Obstetrics, vol. 89, no. 2, pp. 127–132, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. R. A. Calderone and W. A. Fonzi, “Virulence factors of Candida albicans,” Trends in Microbiology, vol. 9, no. 7, pp. 327–335, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. L. J. Douglas, “Candida biofilms and their role in infection,” Trends in Microbiology, vol. 11, no. 1, pp. 30–36, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. D. P. Camacho, M. E. L. Consolaro, E. V. Patussi, L. Donatti, A. Gasparetto, and T. I. E. Svidzinski, “Vaginal yeast adherence to the combined contraceptive vaginal ring (CCVR),” Contraception, vol. 76, no. 6, pp. 439–443, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. M. L. Bruschi, D. S. Jones, H. Panzeri, M. P. D. Gremião, O. de Freitas, and E. H. G. Lara, “Semisolid systems containing propolis for the treatment of periodontal disease: in vitro release kinetics, syringeability, rheological, textural, and mucoadhesive properties,” Journal of Pharmaceutical Sciences, vol. 96, no. 8, pp. 2074–2089, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. M. L. Bruschi, T. Klein, R. S. Lopes, S. L. Franco, and M. P. D. Gremião, “Contribuição ao protocolo de controle de qualidade da própolis e de seus extratos,” Revista de Ciências Farmacêuticas, vol. 23, no. 2, pp. 289–306, 2002. View at Google Scholar
  15. Farmacopeia Brasileira, vol. 1-2, Agência Nacional de Vigilância Sanitária, Brasília, Brazil, 5th edition, 2010.
  16. R. R. A. Pereira and M. L. Bruschi, “Evaluation of two spectrophotometric methods for analysis of green propolis extract,” Latin American Journal of Pharmacy, vol. 32, no. 5, pp. 719–726, 2013. View at Google Scholar · View at Scopus
  17. Clinical and Laboratory Standards Institute (CLSI), Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard, CLSI Document M27-A3, 3rd edition, 2008.
  18. K. F. Dalben-Dota, M. G. I. Faria, M. L. Bruschi, S. M. Pelloso, M. E. Lopes-Consolaro, and T. I. E. Svidzinski, “Antifungal activity of propolis extract against yeasts isolated from vaginal exudates,” The Journal of Alternative and Complementary Medicine, vol. 16, no. 3, pp. 285–290, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. M. S. A. Khan and I. Ahmad, “Biofilm inhibition by Cymbopogon citratus and Syzygium aromaticum essential oils in the strains of Candida albicans,” Journal of Ethnopharmacology, vol. 140, no. 2, pp. 416–423, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. Clinical and Laboratory Standards Institute (CLSI), “Reference method for broth dilution antifungal susceptibility testing of yeasts,” Approved Standard 3rd Informational Supplement, M27-S3, CLSI, Wayne, Pa, USA, 2008. View at Google Scholar
  21. G. Malich, B. Markovic, and C. Winder, “The sensitivity and specificity of the MTS tetrazolium assay for detecting the in vitro cytotoxicity of 20 chemicals using human cell lines,” Toxicology, vol. 124, no. 3, pp. 179–192, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. J. H. Shin, S. J. Kee, M. G. Shin et al., “Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources,” Journal of Clinical Microbiology, vol. 40, no. 4, pp. 1244–1248, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Negri, V. Gonçalves, S. Silva, M. Henriques, J. Azeredo, and R. Oliveira, “Crystal violet staining to quantity Candida adhesion to epithelial cells,” British Journal of Biomedical Science, vol. 67, no. 3, pp. 120–125, 2010. View at Google Scholar · View at Scopus
  24. M. Negri, S. Silva, M. Henriques, J. Azeredo, T. Svidzinski, and R. Oliveira, “Candida tropicalis biofilms: artificial urine, urinary catheters and flow model,” Medical Mycology, vol. 49, no. 7, pp. 739–747, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. J. C. P. Mello, L. A. Mentz, and P. R. Petrovick, Farmacognosia: da planta ao medicamento, EFRGS, Porto Alegre Rio Grande do Sul, Brazil, 2003.
  26. B. Rankovič, D. Rankovic, and D. Maric, “Antioxidant and antimicrobial activity of some lichen species,” Microbiology, vol. 79, no. 6, pp. 809–815, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. I. de Oliveira, R. A. G. Lima, E. de Oliveira Lima, N. M. P. Farias, and E. L. de Souza, “Atividade antifúngica de óleos essenciais sobre espécies de Candida,” Brazilian Journal of Pharmacognosy, vol. 16, no. 2, pp. 197–201, 2006. View at Google Scholar
  28. S. Sonmez, L. Kirilmaz, M. Yucesoy, B. Yücel, and B. Yilmaz, “The effect of bee propolis on oral pathogens and human gingival fibroblasts,” Journal of Ethnopharmacology, vol. 102, no. 3, pp. 371–376, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. T. P. Cushnie and A. J. Lamb, “Antimicrobial activity of flavonoids,” International Journal of Antimicrobial Agents, vol. 26, no. 5, pp. 343–356, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. Farmacopéia Brasileira, Atheneu, São Paulo, Brazil, 4th edition, 1988.
  31. Y. Jin, H. K. Yip, Y. H. Samaranayake, J. Y. Yau, and L. P. Samaranayake, “Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection,” Journal of Clinical Microbiology, vol. 41, no. 7, pp. 2961–2967, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. M. M. Coogan, P. L. Fidel Jr., M. C. Komesu, N. Maeda, and L. P. Samaranayake, “(B1) Candida and mycotic infections,” Advances in Dental Research, vol. 19, no. 1, pp. 130–138, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. A. A. Basma, Z. Zuraini, and S. Sasidharan, “A transmission electron microscopy study of the diversity of Candida albicans cells induced by Euphorbia hirta L. leaf extract in vitro,” Asian Pacific Journal of Tropical Biomedicine, vol. 1, no. 1, pp. 20–22, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. J.-D. Zhang, Z. Xu, Y.-B. Cao et al., “Antifungal activities and action mechanisms of compounds from Tribulus terrestris L,” Journal of Ethnopharmacology, vol. 103, no. 1, pp. 76–84, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. J. A. Lee and H. Y. Chee, “In vitro antifungal activity of equol against Candida albicans,” Mycobiology, vol. 38, no. 4, pp. 328–330, 2010. View at Google Scholar
  36. A. Khodavandi, F. Alizadeh, F. Aala, Z. Sekawi, and P. P. Chong, “In vitro investigation of antifungal activity of allicin alone and in combination with azoles against Candida species,” Mycopathologia, vol. 169, no. 4, pp. 287–295, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. C. O. D. S. Frozza, C. S. C. Garcia, G. Gambato et al., “Chemical characterization, antioxidant and cytotoxic activities of Brazilian red propolis,” Food and Chemical Toxicology, vol. 52, pp. 137–142, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. G. Agarwal, G. G. Vemanaradhya, and D. S. Mehta, “Evaluation of chemical composition and efficacy of Chinese propolis extract on Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans: an in vitro study,” Contemporary Clinical Dentistry, vol. 3, no. 3, p. 256, 2012. View at Publisher · View at Google Scholar
  39. V. Bankova, “Chemical diversity of propolis makes it a valuable source of new biologically active compounds,” Journal of ApiProduct and ApiMedical Science, vol. 1, no. 2, pp. 23–28, 2009. View at Google Scholar
  40. M. Barbarić, K. Mišković, M. Bojić et al., “Chemical composition of the ethanolic propolis extracts and its effect on HeLa cells,” Journal of Ethnopharmacology, vol. 135, no. 3, pp. 772–778, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. A. A. Berretta, P. A. De Castro, A. H. Cavalheiro et al., “Evaluation of mucoadhesive gels with propolis (EPP-AF) in preclinical treatment of candidiasis vulvovaginal infection,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 641480, 18 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. R. R. A. Pereira, J. S. Ribeiro Godoy, T. I. Stivalet Svidzinski, and M. L. Bruschi, “Preparation and characterization of mucoadhesive thermoresponsive systems containing propolis for the treatment of vulvovaginal candidiasis,” Journal of Pharmaceutical Sciences, vol. 102, no. 4, pp. 1222–1234, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. C. J. Diskin, T. J. Stokes, L. M. Dansby, L. Radcliff, and T. B. Carter, “Is systemic heparin a risk factor for catheter-related sepsis in dialysis patients? An evaluation of various biofilm and traditional risk factors,” Nephron Clinical Practice, vol. 107, no. 4, pp. c128–c132, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. L. J. Douglas, “Medical importance of biofilms in Candida infections,” Revista Iberoamericana de Micologia, vol. 19, no. 3, pp. 139–143, 2002. View at Google Scholar · View at Scopus
  45. A. Valentín, E. Cantón, J. Pemán, and G. Quindós, “In vitro activity of amphotericin B and anidulafungin against Candida spp. biofilms,” Revista Iberoamericana de Micología, vol. 24, no. 4, pp. 272–277, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. P. A. de Castro, V. L. P. Bom, N. A. Brown et al., “Identification of the cell targets important for propolis-induced cell death in Candida albicans,” Fungal Genetics and Biology, vol. 60, pp. 74–86, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. M. A. Al-Fattani and L. J. Douglas, “Biofilm matrix of Candida albicans and Candida tropicalis: Chemical composition and role in drug resistance,” Journal of Medical Microbiology, vol. 55, no. 8, pp. 999–1008, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. V. C. P. P. Queiroz, Avaliação do potencial antifúngico de própolis de Apis mellifera contra leveduras do gênero Candida [dissertação de mestrado], Universidade Estadual de Campinas, Faculdade de Odontologia de Piracicaba, São Paulo, Brazil, 2010.
  49. F. C. Odds, “Pathogenesis of Candida infections,” Journal of the American Academy of Dermatology, vol. 31, no. 3, pp. S2–S5, 1994. View at Publisher · View at Google Scholar · View at Scopus